Type 2 Diabetes Trial, Recruiting NCT07678736 Sponsor: University Ghent Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT07678736
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are male or female
  • People aged between 20 and 30 years old
  • People with a body mass index (BMI) below 35
  • People who are generally healthy, with no diagnosed long-term (chronic) conditions

Who may not be able to join:

  • People who have a long-term (chronic) condition that could affect the study results
  • People who have a condition that raises their risk of bleeding
  • People who take daily medication that could interfere with the study results
  • People who smoke regularly
  • People who are currently pregnant
  • People who have been unable to move around normally (for example, due to wearing a cast or brace from an injury or illness) for more than one week in the month before the study, or for more than four weeks in the six months before the study
  • People who do more than 10 hours per week of structured physical exercise
  • People who are unwilling or unable to follow the set meal plans that are part of the study — for example, due to food allergies or specific dietary preferences

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00320478312585

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Ghent
Registry
ClinicalTrials.gov
Start date
19 May 2025
Est. completion
31 December 2046

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Whole-body insulin sensitivity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov